Treatment of Exercise-Induced Asthma
For exercise-induced asthma (EIA), an inhaled short-acting β2-agonist (SABA) such as albuterol administered 15 minutes before exercise is the recommended first-line treatment. 1, 2
First-Line Treatment
- Administer an inhaled SABA (such as albuterol) 15 minutes before exercise for optimal prevention of exercise-induced bronchoconstriction (EIB) 1, 2, 3
- The typical dose is two inhalations of albuterol via metered-dose inhaler or 2.5 mg via nebulizer 4
- SABA provides approximately 80% protection against EIB for up to 2 hours 5
- SABA use should be less than daily (ideally less than 4 times per week) to prevent tolerance development 2, 3
When to Add Controller Medications
A controller agent should be added when SABA therapy is needed daily or more frequently 1. Options include:
Daily inhaled corticosteroid (ICS) - recommended for patients with persistent symptoms despite pre-exercise SABA use 1, 2
Daily leukotriene receptor antagonist (LTRA) such as montelukast 1, 2
Mast cell stabilizing agent (such as cromolyn sodium) before exercise 1
Inhaled anticholinergic agent before exercise (weak recommendation) 1
Important Cautions and Considerations
- AVOID daily use of an inhaled long-acting β2-agonist (LABA) as monotherapy due to serious side effect concerns 1, 2
- Tolerance can develop with regular use of β2-agonists, resulting in:
- Excessive use of inhaled sympathomimetic drugs has been associated with fatalities 4
- Paradoxical bronchospasm can occur with albuterol, which can be life-threatening 4
Non-Pharmacological Approaches
Warm-up exercise before planned exercise (interval or combination) 1, 2
- Creates a refractory period of up to 3 hours during which repeat exercise causes less bronchospasm 6
For cold weather exercise, use a mask or device that warms and humidifies the air 1, 2
Additional options for patients interested in dietary modifications:
Treatment Algorithm
Start with pre-exercise SABA (15 minutes before activity) 1, 2
If symptoms persist or SABA is needed daily:
For patients with EIB and allergies who continue to have symptoms despite other treatments:
For all patients:
Regular monitoring is essential as worsening EIB symptoms may indicate deteriorating asthma control requiring reassessment of therapy 4, 8, 9.